Literature DB >> 24247819

miR-146a gene polymorphism rs2910164 and the risk of digestive tumors: A meta-analysis of 21 case-control studies.

Xiaohui Xu1, Xiaodong Yang, Gan Ru, Yong Wu, Shuyu Zhang, Chungen Xing, Yongyou Wu, Jianping Cao.   

Abstract

Digestive tumors have the highest incidence among all tumor types worldwide. miR-146a has been shown to play an important role in the development, apoptosis, invasion and metastasis of digestive tumors. Additionally, a miR-146a gene polymorphism has been associated with the risk of a variety of cancer types in the digestive system. Therefore, in order to investigate the correlation, a meta-analysis of reported data was conducted, for which we obtained 21 research studies concerning the association between the miR-146a gene polymorphism and digestive tumors. Odds ratio (OR) values and 95% confidence intervals (95% CI) were used to assess this association. We found that the miR-146a polymorphism rs2910164 might significantly increase the susceptibility of digestive tumors, in particular for esophageal cancer and colorectal cancers. Furthermore, the miR-146a polymorphism might significantly increase the risk of digestive tumors in Asians. However, no obvious correlation between the polymorphism and the risk for digestive tumors was found in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247819     DOI: 10.3892/or.2013.2854

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  MicroRNAs used as novel biomarkers for detecting cancer metastasis.

Authors:  Chunshan Han; Haixiang Yu; Lening Zhang; Xiaoli Li; Yonggang Feng; Hua Xin
Journal:  Tumour Biol       Date:  2014-10-31

Review 2.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

Review 3.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

4.  MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis.

Authors:  Zhong Xu; Lingling Zhang; Hui Cao; Banjun Bai
Journal:  BMC Med Genet       Date:  2014-10-20       Impact factor: 2.103

Review 5.  Effects of Two Common Polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on Gastric Cancer Susceptibility.

Authors:  Qing Ni; Anlai Ji; Junfeng Yin; Xiangjun Wang; Xinnong Liu
Journal:  Gastroenterol Res Pract       Date:  2015-04-23       Impact factor: 2.260

6.  Lack of Association between miRNA-146a rs2910164 and miRNA-499 rs3746444 Gene Polymorphisms and Susceptibility to Pulmonary Tuberculosis.

Authors:  Mohammad Naderi; Mohammad Hashemi; Parisa Khorgami; Maliheh Koshki; Mahboubeh Ebrahimi; Shadi Amininia; Batool Sharifi-Mood; Mohsen Taheri
Journal:  Int J Mol Cell Med       Date:  2015

7.  MicroRNA gene polymorphisms and the risk of colorectal cancer.

Authors:  Guo-Qiang Rong; Xin-Mei Zhang; Bo Chen; Xiao-Dong Yang; Hao-Rong Wu; Wei Gong
Journal:  Oncol Lett       Date:  2017-03-21       Impact factor: 2.967

8.  miR-146a promotes growth of osteosarcoma cells by targeting ZNRF3/GSK-3β/β-catenin signaling pathway.

Authors:  Chun Zhou; Chang-Qing Jiang; Zhen Zong; Jia-Chen Lin; Li-Feng Lao
Journal:  Oncotarget       Date:  2017-07-19

Review 9.  Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior.

Authors:  Francisca Dias; Mariana Morais; Ana Luísa Teixeira; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-10-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.